Skip to search formSkip to main contentSkip to account menu

Enkorten

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Drug CombinationsMethionine Enkephalinalpha-Melanocyte stimulating hormone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
8 Enkorten – A Potential Drug for the Treatment of Rheumatoid Arthritis
2009
2009
PO10-TU-41 Effects of Enkorten therapy on relapse related parameters in patients suffering from relapsing-remitting multiple sclerosis (RRMS)
2009
2009
PO10-TU-42 Improvement of disability level with Enkorten therapy in patients suffering from relapsing-remitting multiple sclerosis (RRMS)
2009
2009
FP36-WE-04 Enkorten administration and its effects on gadolinium enhanced T1 and PD/T2 magnetic resonance imaging (MRI) lesions in patients suffering from relapsing-remitting multiple sclerosis (RRMS…
Review
2008
Review
2008
[Pharmacodynamic properties of a combination of met-enkephalin and alpha 1-13 adrenocorticotropic hormone].
ENKORTEN is newly registered drug in Bosnia and Herzegovina. It consists of two peptide components: met-enkephalin and alpha 1-13… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)